Add like
Add dislike
Add to saved papers

Incidence of hypertrophic and keloid scars after N-butyl 2-cyanoacrylate tissue adhesive had been used to close parotidectomy wounds: a prospective study of 100 consecutive patients.

Suturing is the usual technique for cutaneous wound closure after parotidectomy and gives a satisfactory aesthetic appearance for most patients. Late complications include the development of hypertrophic and keloid scars, the incidence of which ranges from 5% to 16% in elective cases. We studied the use of N-butyl 2-cyanoacrylate (Indermil) for closure of parotid wounds in 100 consecutive patients over a period of 7 years, our main aim being to establish the incidence of hypertrophic and keloid scars after the use of Indermil. We also wanted to explore the potential advantages of this technique as an alternative method of wound closure. The incidence of hypertrophic and keloid scars was 8 and 9, respectively. The technique is simple and safe, and the incidence of hypertrophic and keloid scars within the accepted range for sutures.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app